Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Patient-clinician interactions and disparities in breast cancer care: the equality in breast cancer care study.

Gonzales FA, Sangaramoorthy M, Dwyer LA, Shariff-Marco S, Allen AM, Kurian AW, Yang J, Langer MM, Allen L, Reeve BB, Taplin SH, Gomez SL.

J Cancer Surviv. 2019 Dec;13(6):968-980. doi: 10.1007/s11764-019-00820-7. Epub 2019 Oct 23.

PMID:
31646462
2.
3.
4.

Sociodemographic correlates of cancer fatalism and the moderating role of religiosity: Results from a nationally-representative survey.

Leyva B, Nguyen AB, Cuevas A, Taplin SH, Moser RP, Allen JD.

J Prev Interv Community. 2019 Jul 11:1-18. doi: 10.1080/10852352.2019.1617521. [Epub ahead of print]

PMID:
31293220
5.

Needing More to Understand Breast Cancer Screening Adherence: Multilevel Analysis.

Taplin SH.

J Womens Health (Larchmt). 2019 Aug;28(8):1011-1012. doi: 10.1089/jwh.2018.7637. Epub 2019 Mar 23. No abstract available.

PMID:
30907680
6.

Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial.

Coronado GD, Petrik AF, Vollmer WM, Taplin SH, Keast EM, Fields S, Green BB.

JAMA Intern Med. 2018 Sep 1;178(9):1174-1181. doi: 10.1001/jamainternmed.2018.3629. Erratum in: JAMA Intern Med. 2019 Jul 1;179(7):1007.

7.

Mapping Multi-Site Clinic Workflows to Design Systems-Enabled Interventions.

Coronado GD, Retecki S, Petrik AF, Coury J, Aguirre J, Taplin SH, Burdick T, Green BB.

EGEMS (Wash DC). 2017 Jun 14;5(1):13. doi: 10.5334/egems.219.

8.

Lay Beliefs About the Accuracy and Value of Cancer Screening.

Roberts MC, Ferrer RA, Rendle KA, Kobrin SC, Taplin SH, Hesse BW, Klein WMP.

Am J Prev Med. 2018 May;54(5):699-703. doi: 10.1016/j.amepre.2018.02.002. Epub 2018 Mar 16.

9.

An Exploration of Changes in the Measurement of Mammography in the National Health Interview Survey.

Gonzales FA, Willis GB, Breen N, Yan T, Cronin KA, Taplin SH, Yu M.

Cancer Epidemiol Biomarkers Prev. 2017 Nov;26(11):1611-1618. doi: 10.1158/1055-9965.EPI-17-0213. Epub 2017 Sep 8.

10.

Applying the Plan-Do-Study-Act (PDSA) approach to a large pragmatic study involving safety net clinics.

Coury J, Schneider JL, Rivelli JS, Petrik AF, Seibel E, D'Agostini B, Taplin SH, Green BB, Coronado GD.

BMC Health Serv Res. 2017 Jun 19;17(1):411. doi: 10.1186/s12913-017-2364-3.

11.

Geospatial Approaches to Cancer Control and Population Sciences.

Schootman M, Gomez SL, Henry KA, Paskett ED, Ellison GL, Oh A, Taplin SH, Tatalovich Z, Berrigan DA.

Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):472-475. doi: 10.1158/1055-9965.EPI-17-0104. Epub 2017 Mar 21.

12.

National Cancer Institute-American Society of Clinical Oncology Teams in Cancer Care Project.

Kosty MP, Hanley A, Chollette V, Bruinooge SS, Taplin SH.

J Oncol Pract. 2016 Nov;12(11):955-958. Epub 2016 Oct 24. No abstract available.

PMID:
27756798
13.

Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.

Leyva B, Persoskie A, Ottenbacher A, Hamilton JG, Allen JD, Kobrin SC, Taplin SH.

J Cancer Educ. 2016 Dec;31(4):693-701. doi: 10.1007/s13187-015-0870-8.

14.

Radiologists' interpretive skills in screening vs. diagnostic mammography: are they related?

Elmore JG, Cook AJ, Bogart A, Carney PA, Geller BM, Taplin SH, Buist DS, Onega T, Lee CI, Miglioretti DL.

Clin Imaging. 2016 Nov - Dec;40(6):1096-1103. doi: 10.1016/j.clinimag.2016.06.014. Epub 2016 Jul 1.

15.

Receipt of mammography recommendations among White and non-White women before and after the 2009 United States Preventive Services Task Force recommendation change.

Gonzales FA, Taplin SH, Yu M, Breen N, Cronin KA.

Cancer Causes Control. 2016 Aug;27(8):977-87. doi: 10.1007/s10552-016-0775-9. Epub 2016 Jun 28.

PMID:
27351918
16.

Recruiting community health centers into pragmatic research: Findings from STOP CRC.

Coronado GD, Retecki S, Schneider J, Taplin SH, Burdick T, Green BB.

Clin Trials. 2016 Apr;13(2):214-22. doi: 10.1177/1740774515608122. Epub 2015 Sep 29.

17.

Misclassification of Breast Imaging Reporting and Data System (BI-RADS) Mammographic Density and Implications for Breast Density Reporting Legislation.

Gard CC, Aiello Bowles EJ, Miglioretti DL, Taplin SH, Rutter CM.

Breast J. 2015 Sep-Oct;21(5):481-9. doi: 10.1111/tbj.12443. Epub 2015 Jul 1.

18.

Teams and teamwork during a cancer diagnosis: interdependency within and between teams.

Taplin SH, Weaver S, Chollette V, Marks LB, Jacobs A, Schiff G, Stricker CT, Bruinooge SS, Salas E.

J Oncol Pract. 2015 May;11(3):231-8. doi: 10.1200/JOP.2014.003376. Epub 2015 Apr 14.

19.

Reviewing cancer care team effectiveness.

Taplin SH, Weaver S, Salas E, Chollette V, Edwards HM, Bruinooge SS, Kosty MP.

J Oncol Pract. 2015 May;11(3):239-46. doi: 10.1200/JOP.2014.003350. Epub 2015 Apr 14. Review.

20.

Sharing care to achieve the triple aim of health care delivery.

Taplin SH.

J Oncol Pract. 2014 Sep;10(5):306-7. doi: 10.1200/JOP.2014.000869. No abstract available.

PMID:
25232188
21.

Follow-up to abnormal cancer screening tests: considering the multilevel context of care.

Zapka JM, Edwards HM, Chollette V, Taplin SH.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):1965-73. doi: 10.1158/1055-9965.EPI-14-0454. Epub 2014 Jul 29. Review.

22.

Effect of radiologists' diagnostic work-up volume on interpretive performance.

Buist DS, Anderson ML, Smith RA, Carney PA, Miglioretti DL, Monsees BS, Sickles EA, Taplin SH, Geller BM, Yankaskas BC, Onega TL.

Radiology. 2014 Nov;273(2):351-64. doi: 10.1148/radiol.14132806. Epub 2014 Jun 24.

23.

Strategies and Opportunities to STOP Colon Cancer in Priority Populations: design of a cluster-randomized pragmatic trial.

Coronado GD, Vollmer WM, Petrik A, Taplin SH, Burdick TE, Meenan RT, Green BB.

Contemp Clin Trials. 2014 Jul;38(2):344-9. doi: 10.1016/j.cct.2014.06.006. Epub 2014 Jun 14.

24.

Is religiosity associated with cancer screening? Results from a national survey.

Leyva B, Nguyen AB, Allen JD, Taplin SH, Moser RP.

J Relig Health. 2015 Jun;54(3):998-1013. doi: 10.1007/s10943-014-9843-1.

25.

Cancer screening and genetics: a tale of two paradigms.

Hamilton JG, Edwards HM, Khoury MJ, Taplin SH.

Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):909-16. doi: 10.1158/1055-9965.EPI-13-1016. Epub 2014 Apr 4.

26.

Behavioral research in cancer prevention and control: a look to the future.

Klein WM, Bloch M, Hesse BW, McDonald PG, Nebeling L, O'Connell ME, Riley WT, Taplin SH, Tesauro G.

Am J Prev Med. 2014 Mar;46(3):303-11. doi: 10.1016/j.amepre.2013.10.004. Review.

27.

Organizational leadership for building effective health care teams.

Taplin SH, Foster MK, Shortell SM.

Ann Fam Med. 2013 May-Jun;11(3):279-81. doi: 10.1370/afm.1506.

28.

Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population.

Kamineni A, Anderson ML, White E, Taplin SH, Porter P, Ballard-Barbash R, Malone K, Buist DS.

Cancer Causes Control. 2013 Feb;24(2):305-12. doi: 10.1007/s10552-012-0115-7. Epub 2012 Dec 7.

29.

Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium.

Gierach GL, Ichikawa L, Kerlikowske K, Brinton LA, Farhat GN, Vacek PM, Weaver DL, Schairer C, Taplin SH, Sherman ME.

J Natl Cancer Inst. 2012 Aug 22;104(16):1218-27. doi: 10.1093/jnci/djs327. Epub 2012 Aug 21.

30.

A multilevel research perspective on cancer care delivery: the example of follow-up to an abnormal mammogram.

Taplin SH, Yabroff KR, Zapka J.

Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1709-15. doi: 10.1158/1055-9965.EPI-12-0265. Epub 2012 Aug 21.

31.

Chronic Care Model implementation for cancer screening and follow-up in community health centers.

Haggstrom DA, Taplin SH, Monahan P, Clauser S.

J Health Care Poor Underserved. 2012 Aug;23(3 Suppl):49-66. doi: 10.1353/hpu.2012.0131.

PMID:
22864487
32.

Multilevel intervention research: lessons learned and pathways forward.

Clauser SB, Taplin SH, Foster MK, Fagan P, Kaluzny AD.

J Natl Cancer Inst Monogr. 2012 May;2012(44):127-33. doi: 10.1093/jncimonographs/lgs019.

33.

Summary of the multilevel interventions in health care conference.

Edwards HM, Taplin SH, Chollette V, Clauser SB, Prabhu Das I, Kaluzny AD.

J Natl Cancer Inst Monogr. 2012 May;2012(44):123-6. doi: 10.1093/jncimonographs/lgs018. No abstract available.

34.

Multilevel interventions: study design and analysis issues.

Cleary PD, Gross CP, Zaslavsky AM, Taplin SH.

J Natl Cancer Inst Monogr. 2012 May;2012(44):49-55. doi: 10.1093/jncimonographs/lgs010.

35.

Multilevel factors affecting quality: examples from the cancer care continuum.

Zapka J, Taplin SH, Ganz P, Grunfeld E, Sterba K.

J Natl Cancer Inst Monogr. 2012 May;2012(44):11-9. doi: 10.1093/jncimonographs/lgs005.

36.

Introduction: Understanding and influencing multilevel factors across the cancer care continuum.

Taplin SH, Anhang Price R, Edwards HM, Foster MK, Breslau ES, Chollette V, Prabhu Das I, Clauser SB, Fennell ML, Zapka J.

J Natl Cancer Inst Monogr. 2012 May;2012(44):2-10. doi: 10.1093/jncimonographs/lgs008.

37.

Screening mammography use among current, former, and never hormone therapy users may not explain recent declines in breast cancer incidence.

Buist DS, Walker R, Bowles EJ, Carney PA, Taplin SH, Onega T, Kerlikowske K, Clinton W, Miglioretti DL.

Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):720-7. doi: 10.1158/1055-9965.EPI-11-1115. Epub 2012 Feb 1.

38.

Mammographic interpretive volume and diagnostic mammogram interpretation performance in community practice.

Haneuse S, Buist DS, Miglioretti DL, Anderson ML, Carney PA, Onega T, Geller BM, Kerlikowske K, Rosenberg RD, Yankaskas BC, Elmore JG, Taplin SH, Smith RA, Sickles EA.

Radiology. 2012 Jan;262(1):69-79. doi: 10.1148/radiol.11111026. Epub 2011 Nov 21.

39.

Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study.

Kerlikowske K, Hubbard RA, Miglioretti DL, Geller BM, Yankaskas BC, Lehman CD, Taplin SH, Sickles EA; Breast Cancer Surveillance Consortium.

Ann Intern Med. 2011 Oct 18;155(8):493-502. doi: 10.7326/0003-4819-155-8-201110180-00005.

40.

Systems strategies to support cancer screening in U.S. primary care practice.

Yabroff KR, Zapka J, Klabunde CN, Yuan G, Buckman DW, Haggstrom D, Clauser SB, Miller J, Taplin SH.

Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2471-9. doi: 10.1158/1055-9965.EPI-11-0783. Epub 2011 Oct 5.

41.

Timeliness of follow-up after abnormal screening mammogram: variability of facilities.

Rosenberg RD, Haneuse SJ, Geller BM, Buist DS, Miglioretti DL, Brenner RJ, Smith-Bindman R, Taplin SH; Breast Cancer Surveillance Consortium.

Radiology. 2011 Nov;261(2):404-13. doi: 10.1148/radiol.11102472. Epub 2011 Sep 7.

42.

Was the drop in mammography rates in 2005 associated with the drop in hormone therapy use?

Breen N, Cronin KA, Tiro JA, Meissner HI, McNeel TS, Sabatino SA, Tangka FK, Taplin SH.

Cancer. 2011 Dec 15;117(24):5450-60. doi: 10.1002/cncr.26218. Epub 2011 Aug 22.

43.

Effectiveness of computer-aided detection in community mammography practice.

Fenton JJ, Abraham L, Taplin SH, Geller BM, Carney PA, D'Orsi C, Elmore JG, Barlow WE; Breast Cancer Surveillance Consortium.

J Natl Cancer Inst. 2011 Aug 3;103(15):1152-61. doi: 10.1093/jnci/djr206. Epub 2011 Jul 27.

44.

Influence of annual interpretive volume on screening mammography performance in the United States.

Buist DS, Anderson ML, Haneuse SJ, Sickles EA, Smith RA, Carney PA, Taplin SH, Rosenberg RD, Geller BM, Onega TL, Monsees BS, Bassett LW, Yankaskas BC, Elmore JG, Kerlikowske K, Miglioretti DL.

Radiology. 2011 Apr;259(1):72-84. doi: 10.1148/radiol.10101698. Epub 2011 Feb 22.

45.

Multiple clinical practice guidelines for breast and cervical cancer screening: perceptions of US primary care physicians.

Han PK, Klabunde CN, Breen N, Yuan G, Grauman A, Davis WW, Taplin SH.

Med Care. 2011 Feb;49(2):139-48. doi: 10.1097/MLR.0b013e318202858e.

46.

Accuracy of screening mammography varies by week of menstrual cycle.

Miglioretti DL, Walker R, Weaver DL, Buist DS, Taplin SH, Carney PA, Rosenberg RD, Dignan MB, Zhang ZT, White E.

Radiology. 2011 Feb;258(2):372-9. doi: 10.1148/radiol.10100974. Epub 2010 Dec 3.

47.

Effect of previous benign breast biopsy on the interpretive performance of subsequent screening mammography.

Taplin SH, Abraham L, Geller BM, Yankaskas BC, Buist DS, Smith-Bindman R, Lehman C, Weaver D, Carney PA, Barlow WE.

J Natl Cancer Inst. 2010 Jul 21;102(14):1040-51. doi: 10.1093/jnci/djq233. Epub 2010 Jul 2.

48.

The health disparities cancer collaborative: a case study of practice registry measurement in a quality improvement collaborative.

Haggstrom DA, Clauser SB, Taplin SH.

Implement Sci. 2010 Jun 4;5:42. doi: 10.1186/1748-5908-5-42.

49.

Time trends in radiologists' interpretive performance at screening mammography from the community-based Breast Cancer Surveillance Consortium, 1996-2004.

Ichikawa LE, Barlow WE, Anderson ML, Taplin SH, Geller BM, Brenner RJ; National Cancer Institute-sponsored Breast Cancer Surveillance Consortium.

Radiology. 2010 Jul;256(1):74-82. doi: 10.1148/radiol.10091881. Epub 2010 May 26.

50.

Bioinformatics: Tools to accelerate population science and disease control research.

Forman MR, Greene SM, Avis NE, Taplin SH, Courtney P, Schad PA, Hesse BW, Winn DM.

Am J Prev Med. 2010 Jun;38(6):646-51. doi: 10.1016/j.amepre.2010.03.002. Review.

PMID:
20494241

Supplemental Content

Loading ...
Support Center